These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35446564)

  • 1. Impact of High-Throughput Model Parameterization and Data Uncertainty on Thyroid-Based Toxicological Estimates for Pesticide Chemicals.
    Carlson JM; Janulewicz PA; Kleinstreuer NC; Heiger-Bernays W
    Environ Sci Technol; 2022 May; 56(9):5620-5631. PubMed ID: 35446564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.
    Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK
    Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.
    Paul Friedman K; Gagne M; Loo LH; Karamertzanis P; Netzeva T; Sobanski T; Franzosa JA; Richard AM; Lougee RR; Gissi A; Lee JJ; Angrish M; Dorne JL; Foster S; Raffaele K; Bahadori T; Gwinn MR; Lambert J; Whelan M; Rasenberg M; Barton-Maclaren T; Thomas RS
    Toxicol Sci; 2020 Jan; 173(1):202-225. PubMed ID: 31532525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From vision toward best practices: Evaluating
    Reardon AJF; Farmahin R; Williams A; Meier MJ; Addicks GC; Yauk CL; Matteo G; Atlas E; Harrill J; Everett LJ; Shah I; Judson R; Ramaiahgari S; Ferguson SS; Barton-Maclaren TS
    Front Toxicol; 2023; 5():1194895. PubMed ID: 37288009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infer the in vivo point of departure with ToxCast in vitro assay data using a robust learning approach.
    Wang D
    Arch Toxicol; 2018 Sep; 92(9):2913-2922. PubMed ID: 29995190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Inhalation Exposures and Potential Health Impacts of Ingredient Mixtures Using
    Zhang J; Chang X; Holland TL; Hines DE; Karmaus AL; Bell S; Lee KM
    Front Toxicol; 2021; 3():787756. PubMed ID: 35295123
    [No Abstract]   [Full Text] [Related]  

  • 7. High-throughput PBTK models for
    Breen M; Ring CL; Kreutz A; Goldsmith MR; Wambaugh JF
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):903-921. PubMed ID: 34056988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative in vitro to in vivo extrapolation of genotoxicity data provides protective estimates of in vivo dose.
    Beal MA; Audebert M; Barton-Maclaren T; Battaion H; Bemis JC; Cao X; Chen C; Dertinger SD; Froetschl R; Guo X; Johnson G; Hendriks G; Khoury L; Long AS; Pfuhler S; Settivari RS; Wickramasuriya S; White P
    Environ Mol Mutagen; 2023 Feb; 64(2):105-122. PubMed ID: 36495195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating scientific confidence in the concordance of in vitro and in vivo protective points of departure.
    Lu EH; Ford LC; Chen Z; Burnett SD; Rusyn I; Chiu WA
    Regul Toxicol Pharmacol; 2024 Mar; 148():105596. PubMed ID: 38447894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative In Vitro-to-In Vivo Extrapolation for Mixtures: A Case Study of Superfund Priority List Pesticides.
    Valdiviezo A; Luo YS; Chen Z; Chiu WA; Rusyn I
    Toxicol Sci; 2021 Aug; 183(1):60-69. PubMed ID: 34142158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive interpretation of in vitro micronucleus test results for 292 chemicals: from hazard identification to risk assessment application.
    Kuo B; Beal MA; Wills JW; White PA; Marchetti F; Nong A; Barton-Maclaren TS; Houck K; Yauk CL
    Arch Toxicol; 2022 Jul; 96(7):2067-2085. PubMed ID: 35445829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the effects of experimental parameters and data modeling approaches on in vitro transcriptomic point-of-departure estimates.
    Harrill JA; Everett LJ; Haggard DE; Bundy JL; Willis CM; Shah I; Friedman KP; Basili D; Middleton A; Judson RS
    Toxicology; 2024 Jan; 501():153694. PubMed ID: 38043774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring in vitro to in vivo extrapolation for exposure and health impacts of e-cigarette flavor mixtures.
    Chang X; Abedini J; Bell S; Lee KM
    Toxicol In Vitro; 2021 Apr; 72():105090. PubMed ID: 33440189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an In Vitro Human Thyroid Microtissue Model for Chemical Screening.
    Deisenroth C; Soldatow VY; Ford J; Stewart W; Brinkman C; LeCluyse EL; MacMillan DK; Thomas RS
    Toxicol Sci; 2020 Mar; 174(1):63-78. PubMed ID: 31808822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing utility of thyroid in vitro screening assays through comparisons to observed impacts in vivo.
    Eytcheson SA; Olker JH; Friedman KP; Hornung MW; Degitz SJ
    Regul Toxicol Pharmacol; 2023 Oct; 144():105491. PubMed ID: 37666444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing.
    Wetmore BA; Allen B; Clewell HJ; Parker T; Wambaugh JF; Almond LM; Sochaski MA; Thomas RS
    Toxicol Sci; 2014 Nov; 142(1):210-24. PubMed ID: 25145659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing in vitro bioactivity data to modernize priority setting of chemical inventories.
    Beal MA; Gagne M; Kulkarni SA; Patlewicz G; Thomas RS; Barton-Maclaren TS
    ALTEX; 2022; 39(1):123-139. PubMed ID: 34818430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probabilistic Points of Departure and Reference Doses for Characterizing Human Noncancer and Developmental/Reproductive Effects for 10,145 Chemicals.
    Aurisano N; Jolliet O; Chiu WA; Judson R; Jang S; Unnikrishnan A; Kosnik MB; Fantke P
    Environ Health Perspect; 2023 Mar; 131(3):37016. PubMed ID: 36989077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework.
    Thomas RS; Philbert MA; Auerbach SS; Wetmore BA; Devito MJ; Cote I; Rowlands JC; Whelan MP; Hays SM; Andersen ME; Meek ME; Reiter LW; Lambert JC; Clewell HJ; Stephens ML; Zhao QJ; Wesselkamper SC; Flowers L; Carney EW; Pastoor TP; Petersen DD; Yauk CL; Nong A
    Toxicol Sci; 2013 Nov; 136(1):4-18. PubMed ID: 23958734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Cell Painting for chemical hazard evaluation in support of screening-level chemical assessments.
    Nyffeler J; Willis C; Harris FR; Foster MJ; Chambers B; Culbreth M; Brockway RE; Davidson-Fritz S; Dawson D; Shah I; Friedman KP; Chang D; Everett LJ; Wambaugh JF; Patlewicz G; Harrill JA
    Toxicol Appl Pharmacol; 2023 Jun; 468():116513. PubMed ID: 37044265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.